I have a broad experience in drug development within AstraZeneca and worked across several therapeutic areas since 2000. 十多年了, I supported development of the respiratory pipeline from the clinical programming perspective, led global New Drug Application/Biologics License Application submissions, 监管的反应, Advisory Committee Meeting preparations and Sponsors Inspections (FDA, 教育津贴, PMDA). In 2016, I was honored to receive an internal AstraZeneca Global 药物 发展 Award in the ‘Inspirational Leadership’ category for my ability to inspire, 激励和影响.

在我看来, AstraZeneca is one of the world’s most exciting BioPharmaceutical companies because in recent years it started to embrace AI across the whole of its operations. I was eager to became part of this transformational journey and in 2018 joined the Data Science & AI team within 澳门葡京赌博游戏 R&D. In my role as an AI Product Manager, I bridge the gap between business units and artificial intelligence researchers by understanding and communicating business needs, overseeing development and ensuring delivery of the AI products.

I hold a master’s degree in Computer Science from the Technical University of Moldova.


The use of artificial intelligence in the BioPharmaceutical industry has redefined how scientists develop new drugs, tackle diseases and engage with patients, and I am excited be part of this transformation.

塔蒂阿娜Scetinina Director, Data Science, AstraZeneca

Gayathri Mohankumar, Senior Data Scientist, Computer Vision, AstraZeneca

电流的作用

Director, Data Science, AstraZeneca

2020-2021, Director, Data Science, AstraZeneca

Translated leadership’s vision into the formation of a novel 呼吸 & 免疫学 AI Team and contributed to the overall strategy and management of R&I AI activities by acting as a liaison between technical researchers and general business stakeholders/customers to facilitate understanding of clinical data challenges and linking to AI/ML solutions.

2015-2017, Principal Statistical programmer

Led delivery of statistical analysis and reporting for AstraZeneca’s first respiratory biological global submission and led all post submission regulatory interactions.

2013-2014, Principal Statistical programmer

Delivered statistics and analysis reporting for FDA submission for AstraZeneca product including pivotal trials, legacy data conversion and post submission regulatory interactions.

出版物


OSI Packages: What you need to know for your next NDA or BLA Submission

OSI Packages: What you need to know for your next NDA or BLA Submission. T·德雷尔,T·塞蒂尼娜. 纸# SS05. PharmaSUG 2015

http://www.pharmasug.org/proceedings/2015/SS/PharmaSUG-2015-SS05.pdf


Veeva ID: Z4-66295
Date of preparation: July 2024